Redeye Feed

2024-07-08 10:28:00 Nanologica Q2 2024 - Improvement in production

2024-07-03 08:20:00 Redeye Initiates Coverage of CoinShares

2024-07-02 08:22:00 Systemair - Solid numbers and optimistic outlook

2024-07-02 08:21:00 CLS - Rights issue outcome and focus on neurosurgery

2024-07-01 08:18:00 Redeye Initiates Coverage of Nekkar

2024-06-26 08:51:00 Redeye Initiates Coverage of CTEK

2024-06-20 12:47:00 Fortnox Q2 Preview - Comments on Revised Data and Negligible Changes

2024-06-20 12:42:00 Faron Pharmaceuticals - Approaching pivotal studies

2024-06-20 12:40:00 Biovica - Significant growth at less significant absolut levels

2024-06-20 08:51:00 Verve Group - Acquisition of Jun Group

2024-06-19 10:34:00 Addnode Q2 Preview - Minor Changes

2024-06-17 07:52:00 Redeye Initiates Coverage of Coegin Pharma

2024-06-13 11:38:00 Redeye Initiates Coverage of WntResearch

2024-06-10 08:11:00 PMD Device Solutions - Stable 2024 progress

2024-06-05 08:37:00 Artificial Solutions - Still the only solution in town with live large-scale references

2024-06-04 08:21:00 Q-linea Update - Commercial progress and financial challenges

2024-06-04 08:19:00 Hoylu Q1 Review - Back to Positive Trajectory

2024-06-03 11:09:00 Speqta - Returns to Growth Focus as the Integration Completes

2024-06-03 11:05:00 Integrum - Getting ready for the marathon

2024-06-03 07:49:00 Freemelt - Gaining momentum in the US

2024-06-03 07:45:00 Scibase - Stepping up the pace

2024-05-31 15:39:00 Lytix - Verrica Readout Imminent

2024-05-30 16:51:00 Fluoguide Q1 2024 - Preparing for next steps

2024-05-30 13:35:00 Saniona Q1 - Pipeline progression

2024-05-30 13:30:00 Serstech - Identifying an emerging niche market leader

2024-05-29 10:37:00 Ependion - Creating growth through focus

2024-05-29 10:35:00 Modelon - A rights issue and Modelon Impact picking up steam

2024-05-29 10:33:00 Sleep Cycle - Accelerating growth and promising new goals

2024-05-29 08:03:00 Lipigon Q1 2024 - Phase II Underway

2024-05-28 13:50:00 Beyond Frames - Promising pipeline and healthy revenues

2024-05-28 10:23:00 Lipum Q1 - Initiating preparations for phase II

2024-05-28 10:21:00 Alzniova Q1 - Extended financial runway

2024-05-28 08:13:00 AcouSort - Riding the acoustic wave

2024-05-28 08:09:00 Fortnox - Raised Long-Term Assumptions Following CMD

2024-05-27 14:15:00 Curasight Q1 - Moving forward

2024-05-27 07:59:00 Scandion Oncology Q1 2024 - Funding for CORIST part 3 extension

2024-05-27 07:58:00 Embracer - Stable outlook for 2024/25E

2024-05-24 09:08:00 Northbaze Group - Leaving the tough years behind

2024-05-24 09:06:00 Ortoma - Heading in the right direction

2024-05-24 07:15:00 Dignitana - Sales coming in flat

2024-05-24 07:13:00 Paxman - Strength in numbers

2024-05-24 07:11:00 Calliditas Q1 - Powerful launch momentum

2024-05-23 07:51:00 Better Collective - Solid Q1, uncertainty in Media partnerships

2024-05-22 15:06:00 BeammWave - First quarter with net sales

2024-05-22 07:52:00 Flexion Mobile - Continuing to accumulate cash

2024-05-22 07:46:00 Respiratorius - Liquidity secured

2024-05-22 07:44:00 Maximum Entertainment - Q1 largely as expected, limited changes to estimates

2024-05-22 07:42:00 Cantargia Q1 2024 - Notable Cost Reductions

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden